Search

Filters

Clear Filters
4:55 PM - 5:05 PM PT

172 - The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis
Speaker: Nordlund, Kelsey, BS - MD Anderson Cancer Center, Houston, TX
5:05 PM - 5:15 PM PT

173 - A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma
Speaker: Mitra, Devarati, MD, PhD - University of Texas MD Anderson Cancer Center, Houston, TX
5:15 PM - 5:25 PM PT

174 - Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26
Speaker: Ioakeim-Ioannidou, Myrsini, MD - Massachusetts General Hospital, Boston, MA
5:25 PM - 5:35 PM PT

175 - Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Speaker: Yang, Noel, BS - MD Anderson Cancer Center, Houston, TX
5:35 PM - 5:45 PM PT

176 - Does Dose Avoidance of Uninvolved Skin/Subcutaneous Tissues Reduce Morbidity in Preoperative Intensity-Modulated Radiation Therapy for Soft Tissue Sarcomas of the Lower Extremity?
Speaker: Roohani, Siyer, MD - Princess Margaret Cancer Center, University Health Network, Toronto, ON
8:00 AM - 8:10 AM PT

177 - Development and Validation of a Digital Pathology-Based, Multimodal Artificial Intelligence (MMAI) Biomarker in Patients with Head and Neck Cancer
Speaker: Chinn, Steven, MD - University of Michigan, Ann Arbor, MI
8:10 AM - 8:20 AM PT

178 - Crowdsourcing Tumor Auto-Contouring Solutions for MR-Guided Radiotherapy: The HNTS-MRG 2024 Challenge
Speaker: Wahid, Kareem, PhD - MD Anderson Cancer Center
8:20 AM - 8:30 AM PT

179 - Automated Clinical Target Volume Contour Quality Assurance for the TROG 08.08 TOPGEAR Trial
Speaker: Chlap, Phillip, MS - Radformation, New York, NY
8:30 AM - 8:40 AM PT

180 - Multi-Institutional Validation of the SHIELD-RT Machine Learning Model to Prevent Acute Care Events during Radiotherapy
Speaker: Elia, Marianna, MS, BS - University of California San Francisco, San Francisco, CA
8:40 AM - 8:50 AM PT

181 - Validation of a Digital Twin-Based Clinical Trial Design Approach Combining Radiotherapy and Tyrosine Kinase Inhibitors: Prospective Virtual Trial Predictions Match Real-World Data
Speaker: McClatchy, David, PhD - Massachusetts General Hospital, Boston, MA
8:50 AM - 9:00 AM PT

182 - Predictive Modeling Radiation-Induced Visual Field Deficits for Early Toxicity Detection
Speaker: Thariat, Juliette, MD, PhD - Centre François Baclesse, Caen, Normandy
8:00 AM - 8:10 AM PT

183 - 10-Year Neuropsychological and QoL Outcomes in Pediatric Brain Tumor Survivors: A Comparison of Photon and Proton Cohorts
Speaker: Yock, Torunn, MD, FASTRO, MCH - Massachusetts General Hospital, Boston, MA